CVSHealthcareLarge-Cap

CVS HEALTH Corp Insider Trading Activity

Every SEC Form 4 insider transaction reported for CVS HEALTH Corp (CVS), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are CVS insiders buying or selling?

CVS HEALTH Corp insiders reported 20 open-market buys ($8.5M) and 62 sells ($820.7M) across 82 Form 4 filings — a net selling position of $812.3M.

Source: SEC EDGAR Form 4

Key Statistics (as of May 21, 2026)

Total Form 4 filings
82
SEC EDGAR
Insider filers
26
Insider buys (20)
$8.5M
Insider sells (62)
$820.7M

Insider sentiment

Net selling

Net insider flow of $812.3M in net selling.

Recent CVS insider transactions

DateInsiderRoleTypeSharesPriceValue
May 21, 2026Larry RobbinsDirectorSale3.4M$94.15$317.5M
May 11, 2026Tilak MandadiEVP, Chief Exp & Tech OfficerSale69.6K$89.58$6.2M
Jan 27, 2026Steven H NelsonEVP and President, AetnaPurchase24$53.70$1.3K
Oct 14, 2025Heidi B CapozziEVP and Chief People OfficerPurchase80$57.36$4.6K
Aug 29, 2025Anne A. FinucaneDirectorSale7.5K$71.02$532.6K
Jun 9, 2025Guy P SansoneDirectorPurchase1.6K$63.70$100.0K
May 6, 2025Larry RobbinsDirectorSale3.8M$67.65$253.7M
Mar 7, 2025James David ClarkSVP, Cont & Chief Acct OfficerSale7.5K$66.35$498.5K
Feb 19, 2025Michael F MahoneyDirectorPurchase30.0K$66.70$2.0M
May 2, 2024Edward J LudwigDirectorPurchase1.0K$53.88$53.9K
May 2, 2024Michael F MahoneyDirectorPurchase9.2K$54.49$500.3K
Feb 16, 2024Prem S ShahEVP and Pres-Pharm, Consumer WSale29.5K$76.95$2.3M
Nov 6, 2023Edward J LudwigDirectorPurchase2.0K$70.47$140.9K
May 5, 2023Karen S LynchPresident and CEOPurchase14.0K$69.75$976.6K
Dec 16, 2022Thomas M MoriartyEVP & General CounselSale137.5K$98.36$13.5M
Aug 5, 2022Alan LotvinEVP&President-PharmacyServicesSale143.4K$98.94$14.2M
Aug 5, 2022Daniel P FinkeEVP/Pres, Health Care BenefitsSale9.5K$100.00$954.6K
Jun 30, 2022Thomas M MoriartyEVP & General CounselSale138.7K$95.00$13.2M
Apr 12, 2022Prem S ShahEVP and Co-President of RetailSale17.0K$105.00$1.8M
Apr 6, 2022Daniel P FinkeEVP/Pres, Health Care BenefitsSale61.3K$100.12$6.1M
Mar 31, 2022Prem S ShahEVP and Co-President of RetailSale5.3K$104.70$559.7K
Mar 18, 2022Prem S ShahEVP and Co-President of RetailSale4.6K$106.65$493.1K
Mar 17, 2022Thomas M MoriartyEVP & General CounselSale51.4K$105.00$5.4M
Feb 11, 2022Edward J LudwigDirectorPurchase1.0K$105.90$105.9K
Feb 4, 2022Troyen A BrennanEVP and Chief Medical OfficerSale47.9K$110.00$5.3M

Showing the 25 most recent of 82 Form 4 filings for CVS HEALTH Corp.

Most active CVS insiders

  • Troyen A Brennan9 filings
  • Edward J Ludwig7 filings
  • James David Clark7 filings
  • Thomas M Moriarty7 filings
  • Alan Lotvin6 filings

Ask anything about CVS insider activity

Use Trabud's AI agent to query CVS HEALTH Corp's Form 4 history in plain English — "Show me CVS CEO purchases this year" or compare it against any other ticker.

Open the AI agent

CVS insider trading FAQ

Are CVS HEALTH Corp insiders buying or selling?

Across 82 SEC Form 4 filings, CVS HEALTH Corp (CVS) insiders reported 20 open-market purchases totaling $8.5M and 62 sales totaling $820.7M. That is a net selling position of $812.3M.

How many insiders trade CVS stock?

26 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for CVS HEALTH Corp. The most recent filing was accepted on May 21, 2026.

Where does Trabud get CVS insider trading data?

All CVS insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content